Medsafe Revenue and Competitors
Estimated Revenue & Valuation
- Medsafe's estimated annual revenue is currently $76.9M per year.
- Medsafe's estimated revenue per employee is $297,000
Employee Data
- Medsafe has 259 Employees.
- Medsafe grew their employee count by 3% last year.
Medsafe's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Corporate Purchasing | Reveal Email/Phone |
2 | Director Specialized Accounts | Reveal Email/Phone |
3 | Director Sales - Strategic Accounts | Reveal Email/Phone |
4 | Territory Manager | Reveal Email/Phone |
5 | Corporate Branch Manager | Reveal Email/Phone |
6 | Customer Care Manager | Reveal Email/Phone |
7 | TERRITORY MANAGER | Reveal Email/Phone |
8 | Senior Territory Manager | Reveal Email/Phone |
9 | branch office manager | Reveal Email/Phone |
10 | Branch Office Manager | Reveal Email/Phone |
Medsafe Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $75M | 158 | 3% | N/A | N/A |
What Is Medsafe?
Founded in 1979, Medsafe works out of five fully stocked service facilities in TX, AR, OK, and LA. We have grown into one of the most substantial privately held distributors of industrial safety, occupational health, industrial hygiene, and medical supplies in the United States. At Medsafe, Safety Begins With Us...
keywords:N/AN/A
Total Funding
259
Number of Employees
$76.9M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Medsafe News
This follows Medsafe's provisional approval of the Pfizer COVID-19 vaccine (Comirnaty) as a booster dose for this age group.
Medsafe the country's medicines safety regulator says there is no clear evidence that it is effective to treat or prevent the virus,...
But New Zealand's medicine safety authority, Medsafe, says drinking it can be harmful or fatal and there's no evidence it works.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $91.6M | 273 | -1% | N/A |
#2 | $15M | 307 | 6% | N/A |
#3 | $101.3M | 323 | 8% | N/A |
#4 | $122.5M | 400 | 5% | N/A |
#5 | $126.5M | 413 | 7% | N/A |